Liver Disease

The Department of Hepatology has strong professional and technical capabilities; it is the chairing institution of the Hepatology Professional Committee of the Xinjiang Society of Integrated Chinese and Western Medicine for Liver Diseases and the chairing institution of the Beijing Asia-Pacific Liver Disease Diagnosis and Treatment Technology Alliance. It integrates clinical care, teaching, and research and has distinctive characteristics in integrated Chinese-Western medical diagnosis and treatment. The Department of Hepatology currently has 11 physicians of various ranks, including 4 chief physicians, 5 associate chief physicians, and 2 attending physicians; among them are 1 doctoral supervisor, 2 master's supervisors, 1 physician with doctoral-level education, and 9 with master's-level education; it has trained more than 20 master's students. Professor Wang Xiaozhong serves as deputy director of the Department of Internal Medicine Teaching and Research at Xinjiang Medical University. The department has 11 physicians qualified to supervise standardized residency training and 6 qualified teachers; all have extensive clinical, teaching, and research experience. The Department of Hepatology has distinctive characteristics of traditional Chinese medicine (TCM), and currently has the Le Dexing Studio of the second cohort of National Famous TCM Physicians and the Zeng Binfang Studio of the fifth cohort of Famous Veteran TCM Physicians. The department carries forward the academic thought of veteran TCM professors Le Dexing and Zeng Binfang and has developed Qiyin Granules for the treatment of fatty liver and the Hexue Rougan Formula against hepatic fibrosis; Gan zhuo (viral hepatitis), Gan pi (fatty liver), Ji disease (hepatic fibrosis and compensated cirrhosis), and Gu zhang (decompensated cirrhosis) are among the department’s TCM areas of strength. It routinely performs hepatic artery embolization combined with infusion chemotherapy, artificial liver support therapy, liver puncture biopsy, and, in collaboration with the Department of Spleen and Stomach and the Department of Surgery, esophagogastric variceal ligation and sclerotherapy, liver cancer radiofrequency ablation, and other diagnostic and treatment procedures. At the same time, for patients with acute or chronic liver disease accompanied by hypochondriac pain, abdominal distension, or jaundice, it routinely provides Fugan Ointment + acupoint application therapy, TCM ultrasonic drug-penetration therapy, Chinese herbal medicine pack therapy, Xiaogu Chuzhang Ointment + acupoint application therapy, Fuzheng Juanyin Ointment + acupoint application, thunder-fire moxibustion, and acupuncture, moxibustion, and tuina. The Department of Hepatology is currently a collaborating institution for 2 projects under the National Major Science and Technology Special Project of the “13th Five-Year Plan”. Over the past 5 years, the department has published more than 50 papers in various core journals, published 3 monographs, participated in the compilation of 3 planning textbooks for the 12th and 13th Five-Year Plans, undertaken 3 National Natural Science Foundation projects and more than 10 projects at the autonomous-region and departmental/bureau levels, and participated in more than 30 international and domestic multicenter clinical studies. The Department of Hepatology has successively been designated as the National Demonstration Base for Liver and Gallbladder Disease Prevention and Treatment Technology, the National Center for Standardized Diagnosis and Treatment of Fatty Liver Disease, the Chinese Fatty Liver Disease Clinical Research Collaboration Group, the National Demonstration Center for Artificial Liver and Blood Purification Technology, the institution serving as chair of the Xinjiang Uyghur Autonomous Region Alliance of the Beijing Asia-Pacific Liver Disease Diagnosis and Treatment Technology Alliance, the Silk Road Medical Consortium (Alliance) for the Diagnosis and Treatment of Infectious Diseases, a branch-center hospital of the Chinese Chronic Hepatitis B Clinical Cure (Mount Everest) Project, and a project hospital of the Hepatitis B Zero Mother-to-Child Transmission Project.